Skip to content
10-K

Annual Report

MEDICAL EXERCISE INC.

0001213900-25-063676

← back to feed
Filed
Jul 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jun 27, 2025 12.33M sh
Shares Diluted FY 2025 · Mar 31, 2025 12.19M sh
Shares Diluted FY 2025 · Mar 31, 2024 11.79M sh
Capex FY 2025 · Mar 31, 2025 $3.87K
Capex FY 2025 · Mar 31, 2024 $14.26K
Operating Cash Flow FY 2025 · Mar 31, 2025 −$191.03K
Operating Cash Flow FY 2025 · Mar 31, 2024 −$70.08K
Cash And Equivalents FY 2025 · Mar 31, 2025 $450
Cash And Equivalents FY 2025 · Mar 31, 2024 $10.66K
Stockholders Equity FY 2025 · Mar 31, 2025 −$67.3K
Stockholders Equity FY 2025 · Mar 31, 2024 −$52.31K
Current Liabilities FY 2025 · Mar 31, 2025 $132.56K
Current Liabilities FY 2025 · Mar 31, 2024 $137K
Current Assets FY 2025 · Mar 31, 2025 $450
Current Assets FY 2025 · Mar 31, 2024 $10.66K
Total Assets FY 2025 · Mar 31, 2025 $65.26K
Total Assets FY 2025 · Mar 31, 2024 $84.69K
Eps Diluted FY 2025 · Mar 31, 2025 −$0.03
Eps Diluted FY 2025 · Mar 31, 2024 −$0.01
Eps Basic FY 2025 · Mar 31, 2025 −$0.03
Eps Basic FY 2025 · Mar 31, 2024 −$0.01
Sga Expense FY 2025 · Mar 31, 2025 $176.27K
Sga Expense FY 2025 · Mar 31, 2024 $50.79K
Net Income FY 2025 · Mar 31, 2025 −$330.99K
Net Income FY 2025 · Mar 31, 2024 −$148.01K
Net Income FY 2025 · Mar 31, 2024 −$148.01K
Operating Income FY 2025 · Mar 31, 2025 $849
Operating Income FY 2025 · Mar 31, 2024 $1.98K
Cost Of Revenue FY 2025 · Mar 31, 2025 $445
Cost Of Revenue FY 2025 · Mar 31, 2024 $830
Revenue FY 2025 · Mar 31, 2025 $1.29K
Revenue FY 2025 · Mar 31, 2024 $2.81K